0001708138-21-000096.txt : 20211210
0001708138-21-000096.hdr.sgml : 20211210
20211210173757
ACCESSION NUMBER: 0001708138-21-000096
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211208
FILED AS OF DATE: 20211210
DATE AS OF CHANGE: 20211210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Landry Robert E
CENTRAL INDEX KEY: 0001585160
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 211486432
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2021-12-08
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001585160
Landry Robert E
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
EVP Finance CFO
Common Stock
2021-12-08
4
A
0
3971
0.0
A
29957
D
Common Stock
2021-12-09
4
M
0
4250
399.66
A
34207
D
Common Stock
2021-12-09
4
F
0
3469
657.11
D
30738
D
Common Stock
2021-12-10
4
S
0
2
656.46
D
30736
D
Common Stock
2021-12-10
4
S
0
50
657.53
D
30686
D
Common Stock
2021-12-10
4
S
0
11
658.52
D
30675
D
Common Stock
2021-12-10
4
S
0
4
659.49
D
30671
D
Common Stock
2021-12-10
4
S
0
25
661.48
D
30646
D
Common Stock
2021-12-10
4
S
0
123
662.06
D
30523
D
Common Stock
2021-12-10
4
S
0
19
663.41
D
30504
D
Common Stock
2021-12-10
4
S
0
15
664.71
D
30489
D
Common Stock
2021-12-10
4
S
0
18
665.44
D
30471
D
Common Stock
2021-12-10
4
S
0
68
666.19
D
30403
D
Common Stock
2021-12-10
4
S
0
7
667.8
D
30396
D
Common Stock
2021-12-10
4
S
0
178
668.21
D
30218
D
Common Stock
2021-12-10
4
S
0
130
669.48
D
30088
D
Common Stock
2021-12-10
4
S
0
58
670.13
D
30030
D
Common Stock
2021-12-10
4
S
0
14
671.42
D
30016
D
Common Stock
2021-12-10
4
S
0
59
672.3
D
29957
D
Common Stock
229
I
By 401(k) Plan
Non-Qualified Stock Option (right to buy)
399.66
2021-12-09
4
M
0
4250
0.0
D
2024-12-16
Common Stock
4250
17000
D
Non-Qualified Stock Option (right to buy)
644.54
2021-12-08
4
A
0
16958
0.0
A
2031-12-08
Common Stock
16958
16958
D
Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 8, 2023 and 50% on December 8, 2025.
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 50 shares of Company stock on December 10, 2021 at prices ranging from $657.19 to $657.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
Represents volume-weighted average price of sales of 11 shares of Company stock on December 10, 2021 at prices ranging from $658.10 to $658.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
Represents volume-weighted average price of sales of 4 shares of Company stock on December 10, 2021 at prices ranging from $659.36 to $659.61. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
Represents volume-weighted average price of sales of 25 shares of Company stock on December 10, 2021 at prices ranging from $661.26 to $661.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
Represents volume-weighted average price of sales of 123 shares of Company stock on December 10, 2021 at prices ranging from $662.06 to $662.17. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
Represents volume-weighted average price of sales of 19 shares of Company stock on December 10, 2021 at prices ranging from $663.16 to $663.53. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
Represents volume-weighted average price of sales of 18 shares of Company stock on December 10, 2021 at prices ranging from $665.20 to $665.61. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
Represents volume-weighted average price of sales of 7 shares of Company stock on December 10, 2021 at prices ranging from $667.39 to $667.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
Represents volume-weighted average price of sales of 178 shares of Company stock on December 10, 2021 at prices ranging from $668.10 to $668.50. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
Represents volume-weighted average price of sales of 130 shares of Company stock on December 10, 2021 at prices ranging from $669.43 to $669.75. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
Represents volume-weighted average price of sales of 58 shares of Company stock on December 10, 2021 at prices ranging from $670.12 to $670.62. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
Represents volume-weighted average price of sales of 14 shares of Company stock on December 10, 2021 at prices ranging from $671.42 to $671.43. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
The stock option award vests in four equal annual installments, commencing one year after the date of grant.
/s/**Robert E. Landry
2021-12-10